What is a typical component of a multimodal management plan for spasticity in cerebral palsy?

What is a typical component of a multimodal management plan for spasticity in cerebral palsy?

• A. A multimodal plan typically includes physical therapy, botulinum toxin injections, serial casting, and planning for possible orthopedic surgery.
• B. Only systemic medications are used.
• C. Surgery alone without nonoperative interventions.
• D. Ignore spasticity and focus only on strength training.

Answer: (A)

A multimodal approach to spasticity in cerebral palsy uses a combination of therapies and interventions that address both the nervous system’s influence on muscles and the mechanical, functional outcomes. Physical therapy plays a central role by maintaining range of motion, promoting motor control, and supporting functional activities. Botulinum toxin injections provide focal reduction of tone in specific overactive muscles, helping to improve ease of movement and enable effective therapy. Serial casting or other orthotic strategies help sustain the gains achieved with those injections by lengthening and maintaining muscle-tendon length, reducing the risk of contractures. Planning for orthopedic surgery is considered when fixed contractures or bony deformities limit function despite nonoperative measures, and it aims to improve alignment, stability, and movement potential. Relying solely on systemic medications misses the advantage of targeted, localized control of spasticity; choosing surgery without incorporating nonoperative rehabilitation misses the benefits of strengthening, stretching, and functional goals that rehab provides; and ignoring spasticity altogether and focusing only on strength neglects the primary problem that limits movement and daily activities.

A multimodal approach to spasticity in cerebral palsy uses a combination of therapies and interventions that address both the nervous system’s influence on muscles and the mechanical, functional outcomes. Physical therapy plays a central role by maintaining range of motion, promoting motor control, and supporting functional activities. Botulinum toxin injections provide focal reduction of tone in specific overactive muscles, helping to improve ease of movement and enable effective therapy. Serial casting or other orthotic strategies help sustain the gains achieved with those injections by lengthening and maintaining muscle-tendon length, reducing the risk of contractures. Planning for orthopedic surgery is considered when fixed contractures or bony deformities limit function despite nonoperative measures, and it aims to improve alignment, stability, and movement potential.

Relying solely on systemic medications misses the advantage of targeted, localized control of spasticity; choosing surgery without incorporating nonoperative rehabilitation misses the benefits of strengthening, stretching, and functional goals that rehab provides; and ignoring spasticity altogether and focusing only on strength neglects the primary problem that limits movement and daily activities.